Ascend Wellness Holdings (AAWH) Other Non-Current Liabilities (2022 - 2026)

Ascend Wellness Holdings (AAWH) recorded quarterly Other Non-Current Liabilities of $224.3 million in Q1 2026, up 6.58% quarter-over-quarter from $210.5 million in Q4 2025, and up 29.41% on a YoY basis from $173.3 million in Q1 2025.

Ascend Wellness Holdings (AAWH) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Ascend Wellness Holdings' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $224.3 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities rose 29.41% year-over-year to $224.3 million; the TTM figure through Mar 2026 stood at $224.3 million (up 29.41% YoY), while the FY2025 annual figure was $210.5 million, up 32.46% from the prior year.
  • Other Non-Current Liabilities was $224.3 million for Q1 2026 at Ascend Wellness Holdings, up from $210.5 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $224.3 million in Q1 2026 to a low of $10.0 million in Q2 2022.
  • Historically, Other Non-Current Liabilities has averaged $105.2 million across 5 years, with a median of $110.6 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities rose 12.32% in 2023, then surged 719.98% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $15.1 million in 2022, then soared by 494.29% to $89.6 million in 2023, then jumped by 77.34% to $158.9 million in 2024, then soared by 32.46% to $210.5 million in 2025, then grew by 6.58% to $224.3 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $224.3 million (Q1 2026), $210.5 million (Q4 2025), and $196.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Ascend Wellness Holdings - - 44.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 224.31 Mn
Dec 31, 2025 210.46 Mn
Sep 30, 2025 196.04 Mn
Jun 30, 2025 184.46 Mn
Mar 31, 2025 173.34 Mn
Dec 31, 2024 158.89 Mn
Sep 30, 2024 136.69 Mn
Jun 30, 2024 122.47 Mn
Mar 31, 2024 98.72 Mn
Dec 31, 2023 89.60 Mn
Sep 30, 2023 16.67 Mn
Jun 30, 2023 16.07 Mn
Mar 31, 2023 15.57 Mn
Dec 31, 2022 15.08 Mn
Sep 30, 2022 14.84 Mn
Jun 30, 2022 10.00 Mn